Vitamin D exhibits beneficial immunomodulatory effects in patients with multiple sclerosis

Written by Courtney Johnson

A double-blind, single-center randomized pilot study carried out at Johns Hopkins University (MD, USA) has demonstrated that high-dose vitamin D3 (cholecalciferol) supplementation can result in a reduction in inflammatory T cells that are associated with disease severity in multiple sclerosis (MS). The findings were published recently in the journal Neurology. In MS, there is a correlation between low levels of vitamin D and greater disability and disease activity. Low levels of vitamin D in the blood are also linked to a higher risk of developing the condition. The current study examined the safety and immunologic effects of cholecalciferol administration for...

To view this content, please register now for access

It's completely free